On April 29, Ge Longhui Pharmaceutical (002349.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 367 million yuan, down 11.82% year on year; net profit attributable to shareholders of listed companies was 71.0801 million yuan, down 18.92% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 658.11,500 yuan, down 23.09% year on year; basic earnings per share were 0.0873 yuan.
精华制药(002349.SZ)：一季度净利润7108.01万元 同比下降18.92%
Jinghua Pharmaceutical (002349.SZ): Net profit of 71.081 million yuan in the first quarter decreased by 18.92% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.